Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Tong

Showing results (211-220 of 231) with videos related to

Pageof 24
Sort By:
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial DysfunctionKenji Onda, Stephen Tong, Sally Beard, et al.
American Journal of Obstetrics and Gynecology|February 4, 2017
Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trialKatie M Groom, Lesley M McCowan, Laura K Mackay, et al.
Pregnancy Hypertension|July 29, 2021
LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblastNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
Endocrinology|March 7, 2023
Circulating Chemerin Is Elevated in Women With PreeclampsiaLucy A Bartho, Manju Kandel, Susan P Walker, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 17, 2022
Endothelial protein C receptor is increased in preterm preeclampsia and fetal growth restrictionFaith Andres, Natalie J Hannan, Susan P Walker, et al.
Scientific Reports|October 20, 2021
NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblastNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
American Journal of Obstetrics and Gynecology|July 29, 2018
Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trialCatherine A Cluver, Natalie J Hannan, Erika van Papendorp, et al.
Placenta|February 2, 2021
Circulating Tissue Factor Pathway Inhibitor (TFPI) is increased preceding preeclampsia diagnosis and in established preeclampsiaTeresa M MacDonald, Stephen Tong, Jenny Myers, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
Placental OLAH Levels Are Altered in Fetal Growth Restriction, Preeclampsia and Models of Placental DysfunctionNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
Scientific Reports|March 11, 2021
DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxiaNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
Pageof 24

Showing results (211-220 of 231) with videos related to

Sort By:
Pageof 24
Hypertension (Dallas, Tex. : 1979)|January 25, 2017
Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial DysfunctionKenji Onda, Stephen Tong, Sally Beard, et al.
American Journal of Obstetrics and Gynecology|February 4, 2017
Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trialKatie M Groom, Lesley M McCowan, Laura K Mackay, et al.
Pregnancy Hypertension|July 29, 2021
LOX-1 expression is reduced in placenta from pregnancies complicated by preeclampsia and in hypoxic cytotrophoblastNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
Endocrinology|March 7, 2023
Circulating Chemerin Is Elevated in Women With PreeclampsiaLucy A Bartho, Manju Kandel, Susan P Walker, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 17, 2022
Endothelial protein C receptor is increased in preterm preeclampsia and fetal growth restrictionFaith Andres, Natalie J Hannan, Susan P Walker, et al.
Scientific Reports|October 20, 2021
NR4A2 expression is not altered in placentas from cases of growth restriction or preeclampsia, but is reduced in hypoxic cytotrophoblastNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
American Journal of Obstetrics and Gynecology|July 29, 2018
Esomeprazole to treat women with preterm preeclampsia: a randomized placebo controlled trialCatherine A Cluver, Natalie J Hannan, Erika van Papendorp, et al.
Placenta|February 2, 2021
Circulating Tissue Factor Pathway Inhibitor (TFPI) is increased preceding preeclampsia diagnosis and in established preeclampsiaTeresa M MacDonald, Stephen Tong, Jenny Myers, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
Placental OLAH Levels Are Altered in Fetal Growth Restriction, Preeclampsia and Models of Placental DysfunctionNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
Scientific Reports|March 11, 2021
DAAM2 is elevated in the circulation and placenta in pregnancies complicated by fetal growth restriction and is regulated by hypoxiaNatasha de Alwis, Sally Beard, Natalie K Binder, et al.
Pageof 24